Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

Mark Rosolowsky

Mark Rosolowsky is the executive director of global regulatory sciences–CMC at Bristol Myers Squibb

Articles by Mark Rosolowsky